Sharps Technology sells entire SecureGard inventory; secures multi-year production orders

Sharps Technology Inc.

Signed agreements with a European medical supply company covering Poland, Slovakia, Czech Republic for 1mL and 3mL SecureGard syringes.
Initial shipments and revenue started early December 2024; customer to buy all warehoused SecureGard inventory by Q1 2025.
New production orders from Q2 2025 will consume all current SecureGard capacity of 35 million units annually.
Plans to expand SecureGard capacity to over 100 million units and SoloGard to over 125 million units in Hungary.
Customer expressed interest in U.S. SecureGard inventory for Northern Africa markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.